Ameriprise Financial Inc Arbutus Biopharma Corp Transaction History

Ameriprise Financial Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.24 - $3.06 $2,464 - $3,366	-1,100 Reduced 1.11%	98,000 $225,000
Q1 2023 May 15, 2023	BUY	$2.23 - $3.1 $13,603 - $18,910	6,100 Added 6.56%	99,100 $300,000
Q4 2022 Feb 14, 2023	SELL	$1.91 - $2.85 $82,703 - $123,405	-43,300 Reduced 31.77%	93,000 $216,000
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $55,084 - $84,384	29,300 Added 27.38%	136,300 $260,000
Q2 2022 Aug 15, 2022	SELL	$1.98 - $3.17 $3,775 - $6,045	-1,907 Reduced 1.75%	107,000 $290,000

Q1 2022 May 16, 2022	BUY	$2.42 - $3.98 $8,520 - $14,013	3,521 Added 3.34%	108,907 $324,000
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $126,965 - $188,203	40,825 Added 63.23%	105,386 $410,000
Q3 2021 Nov 15, 2021	SELL	$2.65 - $4.62 $2,809 - $4,897	-1,060 Reduced 1.62%	64,561 $277,000
Q2 2021 Aug 16, 2021	SELL	$2.5 - $3.51 $228,517 - $320,838	-91,407 Reduced 58.21%	65,621 $199,000
Q1 2021 May 17, 2021	SELL	$3.14 - $4.84 $1.51 Million - $2.32 Million	-480,264 Reduced 75.36%	157,028 $523,000
Q4 2020 Feb 12, 2021	SELL	$2.76 - $4.97 $50,251 - $90,488	-18,207 Reduced 2.78%	637,292 $2.26 Million
Q3 2020 Nov 16, 2020	BUY	$1.75 - $6.2 $1.15 Million - $4.06 Million	655,499 New	655,499 $2.05 Million
Q4 2018 Feb 14, 2019	SELL	$3.5 - $9.66 $365,771 - $1.01 Million	-104,506 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.85 - $12.35 $820,372 - $1.29 Million	104,506 New	104,506 $987,000

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $468M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.